2-part placebo-controlled study investigating PK and saftey of AZD1386

• Research type

  Research Study

• Full title

  A Single-centre, Randomised, Double-blind, Placebo-controlled, Two-part Study to Assess Safety, Tolerability, Pharmacokinetics of Orally Administered AZD1386, and the Relationship between Body Temperature and QTc in Healthy Volunteers in the Presence and Absence of Naproxen

• IRAS ID

  26042

• Contact name

  Maura Fallon

• Eudract number

  2009-012114-43

• Research summary

  The study will investigate how a new formulation of the study drug is absorbed, metabolised and distributed through the body, as well as its safety and tolerability in higher doses when given as single and multiple doses.

• REC name

  Scotland A REC

• REC reference

  09/IEC02/8

• Date of REC Opinion

  30 Jul 2009

• REC opinion

  Further Information Favourable Opinion